| David Liebow, DPM | |
|
382 Canal St, Brattleboro, VT 05301-6617 | |
| (802) 254-0202 | |
| (802) 246-1300 |
| Full Name | David Liebow |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 26 Years |
| Location | 382 Canal St, Brattleboro, Vermont |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245220615 | NPI | - | NPPES |
| 19943 | Other | VT | BC/BS VT |
| 30007741 | Medicaid | NH | |
| OVN0942 | Medicaid | VT | |
| 78569 | Other | VT | MVP |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | 0560000157 (Vermont) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Grace Cottage Hospital | Townshend, VT | Hospital |
| Brattleboro Memorial Hospital | Brattleboro, VT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dandk Liebow Llc | 0749289247 | 2 |
News Archive
Oramed Pharmaceuticals Inc., a developer of oral delivery systems, today announced that Oramed entered into a Manufacturing Supply Agreement with sanofi-aventis. According to the MSA, sanofi-aventis will supply Oramed with specified quantities of recombinant human insulin to be used by Oramed for its clinical trials in the USA.
A team of Swedish researchers finds that early cardiopulmonary resuscitation more than doubles the chance of survival for patients suffering out-of-hospital cardiac arrest. The percentage of patients who receive life-saving resuscitation has also increased substantially thanks to so-called SMS Lifesavers.
A team of scientists at the Neuroscience Research Institute at the University of California, Santa Barbara, say they have identified three molecules that appear to stop a key culprit behind Alzheimer's disease.
Otonomy, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of the company's Investigational New Drug (IND) application for the clinical trial of OTO-104 in patients with Meniere's disease, a debilitating disorder of the inner ear affecting balance and hearing.
› Verified 7 days ago
| Provider Name | D&k Liebow Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1184645723 PECOS PAC ID: 0749289247 Enrollment ID: O20070315000002 |
News Archive
Oramed Pharmaceuticals Inc., a developer of oral delivery systems, today announced that Oramed entered into a Manufacturing Supply Agreement with sanofi-aventis. According to the MSA, sanofi-aventis will supply Oramed with specified quantities of recombinant human insulin to be used by Oramed for its clinical trials in the USA.
A team of Swedish researchers finds that early cardiopulmonary resuscitation more than doubles the chance of survival for patients suffering out-of-hospital cardiac arrest. The percentage of patients who receive life-saving resuscitation has also increased substantially thanks to so-called SMS Lifesavers.
A team of scientists at the Neuroscience Research Institute at the University of California, Santa Barbara, say they have identified three molecules that appear to stop a key culprit behind Alzheimer's disease.
Otonomy, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of the company's Investigational New Drug (IND) application for the clinical trial of OTO-104 in patients with Meniere's disease, a debilitating disorder of the inner ear affecting balance and hearing.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Liebow, DPM Po Box 910, Greenfield, MA 01302-0910 Ph: (413) 772-8500 | David Liebow, DPM 382 Canal St, Brattleboro, VT 05301-6617 Ph: (802) 254-0202 |
News Archive
Oramed Pharmaceuticals Inc., a developer of oral delivery systems, today announced that Oramed entered into a Manufacturing Supply Agreement with sanofi-aventis. According to the MSA, sanofi-aventis will supply Oramed with specified quantities of recombinant human insulin to be used by Oramed for its clinical trials in the USA.
A team of Swedish researchers finds that early cardiopulmonary resuscitation more than doubles the chance of survival for patients suffering out-of-hospital cardiac arrest. The percentage of patients who receive life-saving resuscitation has also increased substantially thanks to so-called SMS Lifesavers.
A team of scientists at the Neuroscience Research Institute at the University of California, Santa Barbara, say they have identified three molecules that appear to stop a key culprit behind Alzheimer's disease.
Otonomy, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of the company's Investigational New Drug (IND) application for the clinical trial of OTO-104 in patients with Meniere's disease, a debilitating disorder of the inner ear affecting balance and hearing.
› Verified 7 days ago
Dr. Ethan Andrew Buhl, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 19 Belmont Ave Ofc Building, Brattleboro, VT 05301 Phone: 802-251-8650 | |
Southern Vermont Podiatry Podiatrist Medicare: Medicare Enrolled Practice Location: 382 Canal St, Brattleboro, VT 05301 Phone: 802-254-0202 Fax: 802-246-1300 | |
Kimberly Liebow, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 382 Canal St, Brattleboro, VT 05301 Phone: 802-254-0202 Fax: 802-246-1300 | |
Dr. Raymond Leo Mariani, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 142 Western Ave, Brattleboro, VT 05301 Phone: 802-257-7913 Fax: 802-257-7913 |